Kaplan, N. B. Et Al. 2018. POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME DEVELOPING SECONDARY TO SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA. ACTA MEDICA MEDITERRANEA , vol.34, no.1 , 39-42.

Kaplan, N. B., HARPUTLUOĞLU, H., Dikilitas, M., ELKIRAN, E. T., & TEMELLİ, Ö., (2018). POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME DEVELOPING SECONDARY TO SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA. ACTA MEDICA MEDITERRANEA , vol.34, no.1, 39-42.

Kaplan, Nihal Et Al. "POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME DEVELOPING SECONDARY TO SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA," ACTA MEDICA MEDITERRANEA , vol.34, no.1, 39-42, 2018

Kaplan, Nihal B. Et Al. "POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME DEVELOPING SECONDARY TO SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA." ACTA MEDICA MEDITERRANEA , vol.34, no.1, pp.39-42, 2018

Kaplan, N. B. Et Al. (2018) . "POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME DEVELOPING SECONDARY TO SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA." ACTA MEDICA MEDITERRANEA , vol.34, no.1, pp.39-42.

@article{article, author={Nihal Bozdag Kaplan Et Al. }, title={POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME DEVELOPING SECONDARY TO SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA}, journal={ACTA MEDICA MEDITERRANEA}, year=2018, pages={39-42} }